Brief: Hansa Biopharma Q3 Net Income SEK -103.8 Million
17/10/2024 06:00
Oct 17 (Reuters) - Hansa Biopharma Q3 adjusted EPS SEK -1.53. * Q3 EBIT SEK -116.9 million * Q3 cash & investments SEK 553.5 million * Q3 revenue SEK 78.4 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS